PA
Perceptive Advisors Portfolio holdings
AUM
$2.67B
1-Year Return
73.17%
This Quarter Return
+59.23%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.54B
AUM Growth
+$309M
(+25%)
Cap. Flow
-$78.6M
Cap. Flow
% of AUM
-5.11%
Top 10 Holdings %
Top 10 Hldgs %
50.34%
Holding
230
New
58
Increased
26
Reduced
57
Closed
33
Top Buys
| 1 |
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
|
$21.1M |
| 2 |
RDUS
Radius Health, Inc.
RDUS
|
$17M |
| 3 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$16.9M |
| 4 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$16.2M |
| 5 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$15.4M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$46.2M |
| 2 |
MDVN
MEDIVATION, INC.
MDVN
|
$45.8M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$36.9M |
| 4 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$25.3M |
| 5 |
Sarepta Therapeutics
SRPT
|
$22.8M |
Sector Composition
| 1 | Healthcare | 92.13% |
| 2 | Technology | 0.1% |
| 3 | Consumer Discretionary | 0.08% |
| 4 | Industrials | 0.07% |
| 5 | Consumer Staples | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ardelyx
ARDX
$1.58B
| $13.7M | 0.88% |
1,057,257
+741,302
| +235% | +$9.59M |
|
|
BPMC
27
DELISTED
Blueprint Medicines
BPMC
| $13.7M | 0.88% |
460,024
-4,380
| -0.9% | -$130K |
|
28
Assertio
ASRT
$77.7M
| $13.4M | 0.86% |
133,750
-16,250
| -11% | -$1.62M |
|
|
ALDR
29
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $12.8M | 0.83% |
391,280
-8,720
| -2% | -$286K |
|
|
FOMX
30
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $12.7M | 0.82% |
1,373,284
+578,284
| +73% | +$5.36M |
|
31
Minerva Neurosciences
NERV
$16.2M
| $11.4M | 0.74% |
101,317
| – | – |
|
|
ZYNE
32
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $11.3M | 0.73% |
868,897
+19,547
| +2% | +$255K |
|
|
DERM
33
DELISTED
Dermira, Inc.
DERM
| $11.2M | 0.72% |
331,610
-130,390
| -28% | -$4.41M |
|
34
Clearside Biomedical
CLSD
$27.5M
| $11M | 0.71% |
634,801
-7
| -0% | -$121 |
|
35
Aclaris Therapeutics
ACRS
$224M
| $11M | 0.71% |
+430,000
| New | +$11M |
|
36
Evolent Health
EVH
$1.1B
| $10.5M | 0.68% |
428,284
-444,780
| -51% | -$11M |
|
|
VBIV
37
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $10.5M | 0.68% |
101,948
| – | – |
|
|
MYOK
38
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $10.4M | 0.67% |
634,894
+132,000
| +26% | +$2.16M |
|
39
uniQure
QURE
$973M
| $10M | 0.65% |
1,312,836
-29,257
| -2% | -$224K |
|
40
Vertex Pharmaceuticals
VRTX
$102B
| $9.33M | 0.6% |
107,000
-23,000
| -18% | -$2.01M |
|
41
Cidara Therapeutics
CDTX
$1.65B
| $8.86M | 0.57% |
38,668
-975
| -2% | -$223K |
|
|
FPRX
42
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $8.74M | 0.56% |
166,509
-2,930
| -2% | -$154K |
|
|
FWP
43
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $8.49M | 0.55% |
57,782
+13,296
| +30% | +$1.95M |
|
|
PFNX
44
DELISTED
Pfenex Inc.
PFNX
| $8.41M | 0.54% |
939,930
-20,947
| -2% | -$187K |
|
|
ABMD
45
DELISTED
Abiomed Inc
ABMD
| $8.14M | 0.53% |
63,290
+48,590
| +331% | +$6.25M |
|
46
Abeona Therapeutics
ABEO
$352M
| $8.02M | 0.52% |
53,442
-17,073
| -24% | -$2.56M |
|
|
AVXS
47
DELISTED
AveXis, Inc. Common Stock
AVXS
| $7.83M | 0.51% |
190,000
+188,485
| +12,441% | +$7.77M |
|
48
EyePoint Pharmaceuticals
EYPT
$819M
| $7.68M | 0.5% |
255,243
-11,257
| -4% | -$339K |
|
|
ACHN
49
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $7.53M | 0.49% |
+929,290
| New | +$7.53M |
|
50
Akebia Therapeutics
AKBA
$801M
| $7.3M | 0.47% |
809,096
-84,504
| -9% | -$762K |
|